Kura Oncology, Inc. CEO Troy Edward Wilson buys $1.5M of stock, raising stake 42%
The purchase raises the insider's holding by 42%, the filing shows. Information only, not investment advice.
Insider buying at Kura Oncology, Inc.: Troy Edward Wilson, the company's chief executive officer, bought 200,000 shares between Nov 13 and Nov 16 for $1.5 million, at an average of $7.52 a share, a Form 4 filed on Nov 16 shows.
The filing reports the shares as held indirectly, for example through a trust or a fund. With this purchase the insider holds 679,194 shares, 42% more than before.
The trade was reported within two business days, as Section 16 requires. It is the second insider purchase at Kura Oncology, Inc. reported in the last 90 days.
Details from the SEC filing:
| Company | Kura Oncology, Inc. (KURA) |
|---|---|
| Insider | Troy Edward Wilson |
| Role | CEO |
| Transaction | Open-market purchase (code P) |
| Shares | 200,000 |
| Average price | $7.52 |
| Value | $1,504,765 |
| Trade dates | Nov 13 to Nov 16, 2026 |
| Filed with the SEC | Nov 16, 2026, 7:45 PM ET |
| Shares held after | 679,194 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.